South Korea: Samsung Biologics completes Biogen stake in Samsung Bioepis
Korea-listed absolutely built-in CDMO, Samsung Biologics, has accomplished the acquisition of Biogen’s stake within the Samsung Bioepis three way partnership ...
Korea-listed absolutely built-in CDMO, Samsung Biologics, has accomplished the acquisition of Biogen’s stake within the Samsung Bioepis three way partnership ...
Copyright © 2022 Asia Today.